https://www.selleckchem.com/pr....oducts/jnj-42226314.
Our study suggests selective targeting of SIK2 in ovarian cancer as a therapeutic strategy for overcoming paclitaxel resistance.Prostate cancer is the second most common cancer and the fifth leading cause of cancer-related death among men worldwide [...].Cholangiocarcinoma accounts for approximately 10% of all hepatobiliary tumors and represents 3% of all new-diagnosed malignancies worldwide. Intrahepatic cholangiocarcinoma (i-CCA) accounts for 10% of all cases, perihilar (h-CCA) cholangiocarcinoma represents two-thirds of the case
Like
Comment
Share
